The clinical utility of viral-load and integration status of human papillomavirus (HPV) infection remains uncertain. We examined 75 women infected with HPV58, a worldwide rare type found to be prevalent in cervical cancers in eastern Asia. Viral load was significantly higher for cervical intraepithelial neoplasia (CIN) 1/2, but those for a normal control group and for CIN 3 or cancer overlapped substantially. A pure integrated genome was found for all lesion grades, giving a poor positive predictive value (23.1%) for cancer. The pure episomal form's negative predictive value for cancer was only 76.3%. Mixed patterns of E2 gene disruption were common and often involved the amino-terminal and hinge regions. Disruption of the whole E2 gene was rare and was restricted to high-grade lesions. The HPV58 variant E67-HK-2 was more likely to exist in the pure episomal form. Routinely collected cervical samples contain a heterogeneous population of viruses, hampering the application of viral load and integration testing in clinical settings.
Cervical cancer remains the second leading cancer in females worldwide. Although cytology-based screening has resulted in a substantial reduction in the number of invasive cancers, there is still a need to develop better markers for high-grade cervical lesions and invasive cancers, as a means to improve the accuracy of cervical cancer screening.
Human papillomavirus (HPV) is necessary, although not sufficient, for the development of cervical cancer [1, 2] . Integration of the HPV genome is generally accepted as a prerequisite for cervical cancer development [3, 4] . This notion is based on the in vitro observation that disruption of the E2 gene, resulting from viral integration, abolishes the transcriptional repressive effect that E2 has on viral oncogenes E6 and E7 [5, 6] . Viral integration has therefore been proposed as a surrogate marker for early detection of high-grade lesions and invasive cancers. However, recent studies using sensitive techniques have generated data that cast some doubts on this application. The major concern is that integration of the HPV genome also has been found in low-grade lesions and even in normal cervices [7] [8] [9] . Furthermore, some studies have reported that not all invasive cancers carry the integrated HPV genome [10] [11] [12] [13] .
Viral load is another marker that has been proposed for early detection or prediction of high-grade cervical lesions and invasive cancers. However, the available data have not yet reached a consensus on its clinical value [9, [14] [15] [16] [17] [18] .
The current data on HPV integration and viral load are derived mainly from HPV16, the most common type worldwide. Whether the profile of integration and viral load varies between different types of HPVs is currently unknown. In Hong Kong, a worldwide rare HPV type, HPV58, has a relatively high frequency [19- 
21].
In the present study, we took advantage of this epidemiological feature to examine the integration and viral load of HPV58 in women with different degrees of cervical lesions and to provide a preliminary evaluation on their potential clinical applications.
SUBJECTS AND METHODS
Study subjects. This cross-sectional study was conducted in Hong Kong, where cervical cancer ranks fifth among female cancers, occurring at an age-standardized incidence of 9.6/ 100,000 [22] . Women referred to the colposcopy clinic at Prince of Wales Hospital, for further management because of abnormal results revealed by cervical cytological analysis, were recruited by use of written informed consent; women who were either pregnant or immunocompromised or who had a history of cervical neoplasia or surgery were excluded. A cervical-scrape sample was collected from each subject, to determine whether HPV was present. All subjects were examined by colposcopy and by use of biopsy samples taken from suspicious lesions. Cervical-disease status was defined on the basis of histological findings and was classified as being either cervical intraepithelial neoplasia (CIN) grade 1, 2, or 3 or invasive cervical cancer (ICC). Subjects with normal colposcopy findings-and from whom, therefore, no biopsy samples were taken-were classified as being in the normal control group, provided that the results of follow-up cytology after у6 months were normal. The recruitment sought to identify 15 HPV58-infected cases within each cervical-disease category. HPV detection, typing, and variant identification. The presence of HPV DNA in cervical-scrape samples was detected by polymerase chain reaction (PCR) using consensus primers, PGMY09/PGMY11, targeting the L1 region. HPV type was identified by the Linear Array HPV Genotyping Test (Roche Molecular Systems), which can detect 37 HPV types. Samples found to carry HPV58 were subjected to further analyses, for determination of viral-load, integration, and variant status.
The sequences of the whole E6 and E7 open reading frames were determined by direct sequencing of the PCR amplicons, as described elsewhere [23] .
Viral load, integration, and E2 disruption. The "crude total (i.e., episomal plus integrated forms) viral load" of HPV58 was measured by real-time PCR targeting the E7 gene, which was assumed to be retained in both the episomal and the integrated viral genomes. To account for variation in sample quality, the crude total viral load was normalized in terms of the level of b-actin. "Normalized viral load" was calculated as (E7 copy /b-actin copy ) ϫ 2 and was expressed as viral copies per cell equivalent.
On the basis of the assumption that integration of HPV results in the disruption of the E2 gene, viral integration was inferred by comparing the levels of E2 and E7 genes as measured by real-time PCR. To account for the possibility that disruption might involve only part of the E2 gene, real-time PCR assays targeting 4 nonoverlapping regions of the E2 gene were performed on all samples. The proportion of integrated genome was calculated by use of the ratio E2 copy :E7 copy , where a 0 value indicates that all viral genomes were disrupted, 1 indicates that none were disrupted, and any value between 0 and 1 indicates that some were disrupted. When no disruption was observed in any of the 4 E2 gene amplification targets, the case was classified as being of the "pure episomal" form; on the other hand, when the gene copy number could not be determined by any of the 4 E2 real-time PCR assays, the case was classified as being of the "pure integrated" form; and "concomitant forms" refers to the coexistence of integrated and episomal genomes. Cases were regarded as having mixed patterns of disruption when the profile of gene copy numbers obtained from the 4 real-time PCR assays could not be explained by the loss of a single continuous gene fragment. For the purpose of analysis in the present study, the possibility of integration resulting in disruption outside the E2 gene was not considered. Real-time PCR assays were performed by use of the Power SybrGreen PCR Master Mix with the 7900HT Sequence Detection System (Applied Biosystems). The standard curve for each viral-amplification target was generated from serial 10-fold dilutions of a known concentration of plasmid containing a full-length HPV58 genome (VG040; Health Science Research Resources Bank, Japan Health Sciences Foundation). Quantified preparations from a commercial kit (TaqMan DNA template reagent; Applied Biosystems) were used for generating a standard curve to quantify b-actin levels. The amplification efficiencies of the real-time PCR assays were validated and were found to be the same. All 6 sets of real-time PCR were found to have a wide linear range, from 10 to 10,000,000 copies/mL, and a high amplification efficiency.
A 200-mL aliquot of cervical sample was taken for DNA extraction using a QIAamp DNA Mini Kit (Qiagen). The extracted preparation was eluted to a final volume of 100 mL. This concentration factor was taken into account in the calculation of the gene copy number, which was expressed as copies per microliter of cervical sample. A 5-mL portion of the extracted preparation was amplified in a 25-mL reaction mix containing 0.125 mmol of primer. The primer sequences used for each target are shown in table 1. The cycling conditions were 95ЊC for 10 min and 40 cycles at 95ЊC for 15 s, 60ЊC for 15 s, and 72ЊC for 30 s.
Statistical analysis. The viral-load levels of the groups were compared by use of the Mann-Whitney U test. The distribution in integration patterns were assessed by x 2 test or Fisher's test, as appropriate. All statistical analyses were performed by use of SPSS software (version 11.0). A 2-tailed was regarded P ! .05 as significant.
RESULTS
A total of 75 women with HPV58 infection-15 each in the normal-cervix, CIN 1, CIN 2, CIN 3, and ICC categorieswere recruited. Their age range was 13-78 years (mean ‫ע‬ SD, years). Except for 1 case of adenosquamous-cell 41.9 ‫ע‬ 14.3 carcinoma, all ICC cases were of the squamous-cell type.
Viral load. The normalized total viral load of the 75 samples extended over a wide range: 0.01-copies/cell 5 9.0 ϫ 10 equivalent (median, 56 copies/cell equivalent; interquartile range [IQR], 11-573 copies/cell equivalent). Figure 1 shows the viral load in terms of the degree of cervical lesion. The normalized total viral load for the CIN 1 and CIN 2 groups combined (median, 511 copies/cell equivalent; IQR, 91-1509 copies/cell equivalent) was significantly higher than either that for the normal control group (median, 16 copies/cell equivalent; IQR, 7-38 copies/cell equivalent) or that for the CIN 3 and SCC groups combined (median, 41 copies/cell equivalent; IQR, 9-201 copies/cell equivalent) ( , for both comparisons, P ! .001 by Mann-Whitney U test).
E2-disruption status. Of the 75 samples, 16 (21.3%) did not show any decrease in gene copy number for any of the 4 E2 targets, compared with what was shown for the E7 target, and hence were regarded as having no disruption involving the whole E2 gene-that is, they were regarded as being the pure episomal form; 13 (17.3%) samples showed no detectable gene copy number for at least 1 of the 4 E2 targets and hence were regarded as being the pure integrated form; and the remaining 46 (61.3%) samples showed a mixture of both the episomal and the integrated forms-that is, they were regarded as being concomitant forms. The profile of viral integration and E2 gene disruption, in terms of the degree of cervical lesion, is shown in figure 2 . The proportion of cases with the pure episomal form was lowest for ICC (1/15 [6.7%]) and was highest for . The presence of the pure episomal form of the HPV genome in a cervical sample provided 75.0% specificity and 76.3% negative predictive value for detection of ICC, whereas its sensitivity and positive predictive value for detection of a normal cervix were only 26.7% and 25.0%, respectively.
The proportion of samples with the pure integrated form was lowest for CIN 2 (1/15 [6.7%]) and was the same (3/15 [20%] each) for normal cervix samples, CIN 1, CIN 3, and ICC. The presence of the pure integrated form of HPV genome in a cervical sample provided 83.3% specificity and 80.6% negative predictive value for detection of a normal cervix, whereas its sensitivity and positive predictive value for detection of ICC were only 20.0% and 23.1%, respectively.
Of the 59 samples having the pure integrated viral genome, 52.5% had a single pattern of E2 gene disruption, whereas the remaining 47.5% had mixed patterns of E2 gene disruption. No obvious correlation between a single/mixed disruption pattern and the severity of the cervical lesion was observed (figure 2). Of the 75 studied samples, only 4 (5.3%) had disruption involving the whole E2 gene, and all 4 of these samples were from severe lesions (1 was CIN 3, and 3 were ICC); in contrast, 55 samples had partial disruption of the E2 gene, and the figure 2) . Disruptions involving the amino-terminal 1 portion also were common (57.6% [34/ 59] ). Only 7 cases had disruptions involving the carboxyl end of the E2 gene, and all but 1 of these 7 had severe cervical lesions (2 were CIN 3, and 4 were ICC). Figure 3 shows the distribution of viral load in terms of viralintegration status. Samples having the pure episomal form of the viral genome appeared to have a higher normalized total viral load than did those having the pure integrated form; however, the difference was not statistically significant ( Variants. Of the 75 samples, 23 were found to be HPV58 variant E67-HK-1, as identified by the presence of signature mutations E6 307CrT (silent), E7 694GrA (G41R), E7 744TrG (silent), and E7 761GrA (G63D); another 17 samples were found to be HPV58 variant E67-HK-2, as identified by signature mutations E6 307CrT (silent), E7 632CrT (T20I), E7 744TrG (silent), and E7 760GrA (G63S). The distribution of viral characteristics and cervical pathology, in terms of HPV58-variant status, is shown in table 2. The E67-HK-2 variant group had a significantly higher proportion of the pure episomal form than did the non-E67-HK-2 variants (41.1% vs. 15.5% [P p , by Fisher's exact test]). The 3 variant groups shared a .039 similar profile of E2 gene-disruption involvement, except that the amino-terminal 2 portion was relatively less involved in the E67-HK-2 variant group (table 2). In none of the variants was any significant association between viral load and cervical pathology observed.
Coinfection. Altogether, 43 (57.3%) of the 75 subjects were coinfected with multiple types of HPV; the number of types, in addition to HPV58, that were found in these 43 subjects were as follows: 1 type in 22 (51.2%), 2 types in 12 (27.9%), 3 types in 6 (14.0%), 4 types in 2 (4.7%), and 5 in 1 (2.3%). The most common coinfecting type was HPV16, which was found in 41.9% of coinfections, followed by HPV52 in 39.5%, HPV18 in 11.6%, HPV81 in 9.3%, HPV56/59/84/39/51 in 7.0% each, and HPV31/42 in 4.7% each; the others were HPV6/26/ 54/66/68/73, which were each found in 2.3% (i.e., in 1 sample each).
The viral-load distribution among subjects with HPV58 single-type infection and among subjects coinfected with other types of HPV is shown in figure 4 ; no significant difference between the 2 groups was observed ( , by Mann-Whit-P p .128 ney U test). These 2 groups also shared a similar pattern of viral-genome physical status and location of E2 gene disruption ( 
DISCUSSION
The distribution of HPV58 varies substantially according geographic locations. Although it is found only in ∼2% of cervical cancers worldwide [1, 24] , it occupies the second or third position among cervical-cancer cases in some cities of eastern Asia [25] [26] [27] and Central and South America [28] [29] [30] . The available data on viral load and integration of HPV58 are very limited. Lai et al. [31] have reported that the viral-load profile of HPV58 is different from that of HPV16. The only reported study on HPV58 integration included 10 ICC cases and 19 CIN 2/3 cases [32] . The present study uses a larger sample size and also includes low-grade lesions and a normal control group, to assess the association between HPV58 viral load, integration, and cervical-disease status.
Although the viral-load levels observed among CIN 1/2 cases were significantly higher than those observed in other groups, the levels in the normal control group overlapped substantially with those in the CIN 3 and ICC groups. A previous study reported by Ho et al. [32] did not observe a viral-load difference between CIN 2/3 cases and ICC cases; however, a direct comparison between the findings of the present study and those of Ho et al. [32] cannot be made, because data on low-grade lesions and a normal control group were not available in the latter study. Lai et al. [31] also did not observe any association Table 2 . Viral load, integration, E2 gene disruption, and cervical pathology, in terms of human papillomavirus (HPV)58-infection and -variant status. between HPV58 load and the severity of the cervical lesion. The currently available data, including those of the present study, do not suggest that there is justification for using HPV58-load measurement in clinical settings. Because the episomal form of HPV genome is present during the vegetative replicating phase of the viral life cycle [4] , it is to be expected that viral load would be higher in samples having the pure episomal genome than in those having either the pure integrated form or the concomitant form. The data of the present study, although they do not attain statistical significance, are in line with this expectation.
The findings of the present study indicate that integration of HPV58 commences early during the course of lesion progression. The observation that integration was absent in only 1 of 15 ICC samples and only 2 of 15 CIN 3 samples is in line with the hypothesis that integration is a key, or almost essential, event in the development of HPV58-related cervical cancer. This finding is in contrast to what was observed by Ho et al. [32] , who reported that 7 of 8 cases of HPV58-positive invasive cancers were found to have the pure episomal form. Although both studies employed a highly sensitive technique-that is, real-time PCR-Ho et al. targeted a 108-bp fragment located in the hinge region, to infer E2 gene disruption and hence integration; in contrast, the present study targeted 4 nonoverlapping regions covering the whole E2 gene, an approach that could therefore detect E2 gene disruptions even if they did not involve the hinge region. Nevertheless, the data of the present study show that the hinge region is frequently involved in such disruption. Thus, the difference in the coverage of E2 gene can be only part of the reason for the two studies' different observations. The present study found that a variant of HPV58, E67-HK-2, is associated with a higher chance of existing in the pure episomal form. This observation leads to the question about the possible association between HPV58 variant and susceptibility to integration. It would be worthwhile to further investigate the spectrum of variants circulating in the Taiwanese population examined by Ho et al. [32] . Regardless of whether viral integration is essential for the development of HPV58-associated cervical cancer, its possible variation between viral variants remains to be clarified.
The data of the present study show that only a small proportion of the integrated HPV58 genome had disruption involving the whole E2 gene. As has been reported for HPV16 [7, 13] , these large-fragment disruptions were exclusively found in high-grade lesions. As for the location of the disruption of the HPV58 E2 gene, we found that the amino-terminal and hinge regions were most commonly involved, whereas disruption of the carboxyl-terminal region was rare but was always associated with high-grade lesions. This E2 gene disruption profile is similar to those observed for HPV16 [7, 33] .
More than half of the samples from each grade of cervical lesion and from normal cervices harbored concomitant forms of the viral genome. Mixed patterns of E2 gene disruption were also commonly observed in normal cervices and in all grades of cervical pathology. Such a heterogeneous population of viral genomes in clinical samples poses technical difficulties in the application of integration detection for clinical use. As shown in this present pilot study, the predictive value of using integration as a marker for high-grade lesions, or of using the episomal form as a marker for either normal samples or lowgrade lesions, was low.
Whether viral load and integration are associated with intratypic variant is another area that has been little explored [7, 34] . Because it has been shown that a variant of HPV58 is associated with a higher oncogenic risk [23] , we identified the variant contained in each sample in the present study. We did not observe any correlation between the variant and the viralload level; however, the HPV58 variant E67-HK-2 was found to be more likely to exist in the pure episomal form. The profile of E2 gene disruption also seemed to vary among variants. More data on HPV58 variants are necessary in order to understand the latters' clinical implications, and an international classification system for HPV58 variants will be necessary to allow comparison between studies.
At present, none of the published studies has analyzed the association between coinfection and viral integration. In the present study, we found that ICC cases were more likely to have single-type infection rather than coinfection, a finding that is in line with the hypothesis that HPV58, rather than being a bystander, plays a causative role in the development of cervical cancer. We did not observe any correlation between coinfection and either viral load or integration; however, it should be noted that our sample size was limited. Further studies will be necessary to confirm this observation.
The overall results of the present study imply that routinely collected cervical-scrape samples comprise a heterogeneous population of HPV-infected cells containing different viral loads and that each infected cell may have a heterogeneous population of HPV genomes with a different integration status or pattern. The clinical applicability of viral-load and integration testing requires further evaluation. By itself, disruption involving the E2 gene is not sufficient for an HPV58-infected cervical lesion to progress to invasive cancer.
